Acta Neuropharmacologica››2018,Vol. 8››Issue (1): 9-15.DOI:10.3969/j.issn.2095-1396.2018.01.002
Previous ArticlesNext Articles
LIN Zhi-bin
Online:
2018-02-26Published:
2018-06-04CLC Number:
LIN Zhi-bin.Pharmacological Progress of Ganoderma on Anti-aging and Anti-Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(1): 9-15.
1. Xia Dong, Lin Zhi-bin, Li Rong-zhi, et al. Effects of Ganoderma Polysaccharides on immune function in mice[J]. J Beijing Med Univ, 1989, 21: 533-537. 2. 雷林生, 林志彬. 灵芝多糖对老年小鼠脾细胞DNA多聚酶α活性及免疫功能的影响[J]. 药学学报, 1993, 28(8): 577-582. 3. Li Wen-juan, Nie Shao-ping, Peng Xiao-ping, et al. Ganoderma atrum polysaccharide improves age-related oxidative stress and immune impairment in mice[J]. J Agric Food Chem, 2012, 60(6):1413-8. 4. 雷林生, 林志彬. 灵芝多糖对老年小鼠脾细胞DNA多聚酶α活性及免疫功能的影响[J]. 药学学报, 1993, 28: 577-582 与2重复 5. 林志彬. 灵芝抗氧化清除自由基作用的研究[J]. 菌物研究, 2014, 12(2):63-70. 6. Li Xiang, Liang Jie. Ganoderma lucidum polysaccharide prevents oxidation and skin aging[J]. Chinese J Tissue Engineering Research, 2013, 17( 41):7272-7276. 7. 谢韶琼, 廖万清. 探讨灵芝多糖对H2O2 诱导的角质形成细胞氧化应激性损伤的保护作用[J]. 中国皮肤性病学杂志, 2006, 20(2):77-78. 8. 余强, 聂少平, 李文娟. 黑灵芝多糖对D-半乳糖致衰老小鼠的作用研究[J]. 食品科学, 2009, 30(17):305-307. 9. 魏晓东, 邓连瑞, 张惠丹, 等. 灵芝多糖抗H2 O2 诱导的HDF细胞衰老及其机制的研究[J].中国老年学杂志, 2009, 29(11):1347-1349. 10. Wang Ming-Fu, Chan Yin-Ching, Wu Ching-Lein, et al. Effects of Ganoderma on aging and learning and memory ability in senescence accelerated mice[J]. International Congress Series, 2004, 1260: 399– 404. 11. 郭燕君, 袁华, 甘胜伟, 等. 灵芝多糖对Aβ25-35 诱导阿尔茨海默病模型大鼠脑组织的保护作用[J]. 中国组织化学与细胞化学杂志, 2006, 15: 447-451. 12. 郭燕君, 袁华, 张俐娜, 等. 灵芝多糖对阿尔茨海默病大鼠海马组织形态学及抗氧化能力的影响[J]. 解剖学报, 2006, 37(5): 509-513. 13. 郭燕君, 李平, 袁华. 灵芝多糖对阿尔茨海默病大鼠学习记忆影响及海马细胞凋亡的关系[J]. 解剖学杂志, 2008, 31(3):376-378. 14. 晏涛,陈世保,徐蕾,等. 灵芝多糖对阿尔茨海默病大鼠学习记忆和氧化应激的影响[J].陕西医学杂志, 2011, 40(4):387-425. 15. 张骐,阎志勇,贾学江,等.灵芝多糖肽对氧化应激损伤PC12细胞的保护作用与神经生长因子的比较[J]. 中国临床康复, 2005, 9(32):138-140. 16. 张跃平, 袁华, 黎莉, 等. 灵芝多糖对AD模型大鼠海马组织Caspase-3和FasL表达的影响[J].中国组织化学与细胞化学杂志, 2008, 17(5):484-489. 17. 杨红梅,王黎,陈洁,等. 灵芝多糖肽对Alzheimer样大鼠海马超微结构和抗氧化能力的影响[J]. 中国老年学杂志, 2009, 29(18): 2351-2353. 18. 袁电杰,张印发,姚春香. 灵芝多糖对阿尔茨海默病模型大鼠海马内突触及突触素表达的影响[J].中国实验方剂学杂志, 2011, 3:151-155. 19. 黄勇攀, 刘丙进, 喻南慧, 等. 灵芝三萜类化合物对AD模型大鼠脑组织保护作用的研究[J].贵阳医学院学报, 2008, 33(6):662-664. 20. 张玥,罗俊,黄能慧,等. 灵芝三萜类化合物对AD大鼠学习记忆能力和总抗氧化能力的影响[J]. 中华中医药杂志, 2012, 9:2318-2321. 21. 张玥,罗俊,黄能慧,等. 灵芝三萜类化合物对AD大鼠海马神经元凋亡的影响[J].贵阳医学院报, 2016, 41(5), doi: 10.19367/j.cnki.1000-2707.2016.05.009. 22. Zhou Yan, Qu Ze-qiang, Zeng Yuan-shan, et al. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rathippocampus[J]. Experimental and Toxicologic Pathology, 2012, 64: 673–680. 23. 秦川,吴善球,陈保生, 等.灵芝制剂治疗APP/PS-1 阿尔茨海默病转基因小鼠模型的病理学改变[J]. 中国医学科学院学报, DOI: 10. 3881 /j. issn. 1000-503X. 2017. 04. 015. 24. Ravneet Kaur, Varinder Singh, Richa Shri. Anti-amnesic effects of Ganoderma species: A possible cholinergic and antioxidant mechanism[J]. Biomedicine & Pharmacotherapy,2017, 92:1055–1061. 25. 陶思祥,叶传书. 赤灵芝对老年人细胞免疫功能的影响[J].中华老年医学杂志, 1977, 57: 48. 26. 颜世东,闫社因,齐德芹,等. 芝精口服液治疗阿尔茨海默病93例疗效观察[J]. 广西中医药, 2007, 30(3):154-156. |
[1] | XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8. |
[2] | SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37. |
[3] | WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42. |
[4] | ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64. |
[5] | HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64. |
[6] | ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong.Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7. |
[7] | YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53. |
[8] | ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46. |
[9] | HE Pan, LIU Yue-tao, DU Guan-hua, QIN Xue-mei.Research Advances in Sarcopenia[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 47-53. |
[10] | YANG-Lin,AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64. |
[11] | ZHANG Shuai,AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20. |
[12] | 王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72. |
[13] | CUI Su-ying, SONG Jin-zhi, CUI Xiang-yu, HU Xiao, DING Hui, YE Hui, ZHANG Yong-he.Intracerebroventricular Streptozocin-induced Alzheimer’s Disease-like Sleep Disorders: Role of the GABAergic System in the Parabrachial Complex[J]. Acta Neuropharmacologica, 2018, 8(5): 96-97. |
[14] | YU Li-li1,2,XU Li1,WANG Yi-nuo1,XUE Lu-ning1,Gou Ji-wei1,LI Hong-bo1,HOU Xue-qin1*,ZHANG Han-ting1*.Effects of Osthole on Learning and Memory and the Estrogen Pathway in Ovariectomized Rats[J]. Acta Neuropharmacologica, 2018, 8(4): 7-8. |
[15] | SHEN li-xia1,LIU Liang-liang1,ZHANG Ming1,LIU Yang1,ZHANG Dan-shen 2*.Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms[J]. Acta Neuropharmacologica, 2018, 8(4): 23-25. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||